+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

In-Vitro Diagnostics Market by Product & Service (Instrument, Kits), Technology (Immunoassay, MDx, Hematology, Urinalysis), Application (Diabetes, Oncology, Cardiology, Nephrology, Infectious Diseases) End User (Hospitals) - Global Forecast to 2025

  • ID: 5230081
  • Report
  • November 2020
  • Region: Global
  • 351 Pages
  • Markets and Markets
1 of 6
The Global In-Vitro Diagnostics Market Size is Projected to Reach USD 96.0 Billion by 2025 from USD 84.5 Billion in 2020, at a CAGR of 2.6%

FEATURED COMPANIES

  • Abbott Laboratories, Inc.
  • Biomérieux Sa
  • Danaher Corporation
  • Genomeme
  • Johnson & Johnson
  • Qiagen
  • MORE

The global in-vitro diagnostics market size is projected to reach USD 96.0 billion by 2025 from USD 84.5 billion in 2020, at a CAGR of 2.6% during the forecast period. Market growth is attributed to the rising per capita income in developed and developing countries and technological advancements introduced in the in-vitro diagnostic devices.

By technology, within the IVD market, the immunoassays segment holds the largest share in the forecast period.

Based on technology, the in-vitro diagnostics market has been segmented into immunoassays, clinical chemistry, molecular diagnostics, microbiology, hematology, urinalysis, coagulation, and others. Immunoassays accounted for the largest share of the market in 2019. Significant market share can be associated with increasing investments of leading players such as Roche Diagnostics, Danaher Corporation, Abbott Laboratories, and others in developing superior quality immunoassays. These immunoassays are highly reliable and provide healthcare professionals with an accurate diagnosis that positively impacts the segmental growth.

By application, the oncology segment is expected to grow at the fastest rate during the forecast period (2020-2025).

Based on application, the in-vitro diagnostics market has been segmented into infectious disease, oncology, diabetes, cardiology, drug testing, HIV/AIDS, auto-immune diseases, nephrology, and others. The oncology segment is predicted to have a higher growth rate as compared to other applications due to the increasing prevalence of cancer in developed as well as developing countries. According to WHO, cancer is the second leading cause of death and there is an exponential increase in the number of cancer cases in the past few years. This scenario proves beneficial for the segment growth as it increases the demand for efficient diagnostic tests, thereby, surging the overall industry growth.

North America to hold the largest share.

North America is expected to account for the largest share of the global in-vitro diagnostics market in 2019. The large share of this region can primarily be attributed to the presence of a well-established base of IVD companies, high investments in the IVD devices and software, and increasing R&D expenditure. On the other hand, the APAC is expected to witness the highest CAGR during the forecast period due to a large number of research activities, low cost of operations in APAC countries, and large elderly population base.

The breakdown of primary participants is mentioned below:

  • By Company Type: Tier 1-30%, Tier 2-45%, and Tier 3-25%
  • By Designation: C-level-35%, Director Level-25%, and Others-40%
  • By Region: North America-35%, Europe-30%, the Asia Pacific-15%, Latin America-10%, Middle East & Africa - 10%

Research Coverage:

The report analyzes the various in vitro diagnostics products and their adoption patterns in different applications. It aims at estimating the market size and future growth potential of the global in-vitro diagnostics market for different segments such as by-products and services, technology, application, end-users, and regions. The report also includes an in-depth competitive analysis of the key players in this market, along with their company profiles, product offerings, and recent developments.

Reasons to Buy the Report

The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which would help them garner a greater share. Firms purchasing the report could use one or any combination of the below-mentioned five strategies for strengthening the market.

This report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on the product portfolios offered by the top players in the global in-vitro diagnostics market
  • Product Development/Innovation: Detailed insights on the upcoming trends, R&D activities, and product launches in the global in-vitro diagnostics market
  • Market Development: Comprehensive information on lucrative emerging regions, by-products, and services, application, technology, end-users.
  • Market Diversification: Exhaustive information about new products, growing geographies, and recent developments in the global in-vitro diagnostics market
  • Competitive Assessment: In-depth assessment of market shares, growth strategies, and services offered by leading players in the global in-vitro diagnostics market
Note: Product cover images may vary from those shown
2 of 6

FEATURED COMPANIES

  • Abbott Laboratories, Inc.
  • Biomérieux Sa
  • Danaher Corporation
  • Genomeme
  • Johnson & Johnson
  • Qiagen
  • MORE

1 Introduction
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Inclusions and Exclusions
1.4 Markets Covered
1.5 Years Considered for the Study
1.6 Currency
Table 1 Exchange Rates Utilized for the Conversion to Usd
1.7 Limitations
1.8 Stakeholders
1.9 Summary of Changes

2 Research Methodology
2.1 Research Approach
2.1.1 Research Design
2.1.2 Secondary Research
2.1.2.1 Key Data from Secondary Sources
2.1.3 Primary Research
2.1.4 Primary Sources
2.1.4.1 Key Data from Primary Sources
2.1.4.2 Breakdown of Primaries
Figure 1 Breakdown of Primary Interviews: by Company Type, Designation, and Region
Figure 3 Supply Side Analysis: IVD Market (2019)
Figure 4 Demand Side Approach: Rapid Test Market Size (2019)
Figure 7 CAGR Projections from the Analysis of Market Drivers, Restraints< Opportunities & Challenges of the IVD Industry (2019-2025)
2.6 COVID-19 Health Assessment
2.7 COVID-19 Economic Assessment
2.8 Assessment of the Impact of COVID-19 on the Economic Scenario

3 Executive Summary
Figure 11 In-Vitro Diagnostics Market, by Product & Service, 2020 Vs. 2025 (USD Million)
Figure 12 In-Vitro Diagnostics Market, by Application, 2020 Vs. 2025 (USD Million)
Figure 13 In-Vitro Diagnostics Market, by Technology, 2020 Vs. 2025 (USD Million)
Figure 14 In-Vitro Diagnostics Market, by End-user, 2020 Vs. 2025 (USD Million)
Figure 15 Geographic Snapshot of the In-Vitro Diagnostics Market

4 Premium Insights
4.1 In-Vitro Diagnostics Market Overview
Figure 16 Rising Incidence of Chronic & Infectious Diseases is Driving the Growth of the In-Vitro Diagnostics Market
4.2 Asia-Pacific: In-Vitro Diagnostics Market, by Product & Service and Country (2019)
4.3 In-Vitro Diagnostics Market: Geographic Growth Opportunities
Figure 17 The Market in China is Projected to Register the Highest CAGR in the In-Vitro Diagnostics Market During the Forecast Period
4.4 Geographic Mix: In-Vitro Diagnostics Market
Figure 18 APAC to Witness the Highest Growth in the Forecast Period
4.5 In-Vitro Diagnostics Market: Developed Vs. Developing Markets
Figure 19 Developing Markets to Register a Higher Growth During the Forecast Period

5 Market Overview
5.1 Introduction
5.2 Market Dynamics
Figure 20 In-Vitro Diagnostics Market: Drivers, Restraints, Opportunities, and Challenges
5.2.1 Drivers
5.2.1.1 Rising Geriatric Population and Subsequent Growth in the Prevalence of Chronic and Infectious Diseases
Table 2 Estimated Increase in the Geriatric Population, by Region (2019-2050)
5.2.1.2 Increasing Adoption of Fully Automated and Poc Instruments in Developed Regions
5.2.1.3 Growing Awareness Regarding Disease Diagnosis in Developing Regions
5.2.1.4 Growing R&D Investments by Industry Players to Launch New IVD Products
5.2.2 Restraints
5.2.2.1 Unfavorable Reimbursement Scenario
5.2.3 Opportunities
5.2.3.1 Development of Condition-Specific Markers and Tests
Table 3 New Tests Launched by Key Players
5.2.3.2 Growing Significance of Companion Diagnostics
5.2.3.3 Growth Opportunities in Emerging Countries
5.2.4 Challenges
5.2.4.1 Changing Regulatory Landscape
5.2.4.2 Operational Barriers Faced in Conducting Diagnostic Tests
5.2.5 Impact of COVID-19 on the IVD Market

6 Industry Insights
6.1 Introduction
6.2 Porter's Five Forces Analytical Framework
6.3 PESTLE Analysis
6.4 Industry Ecosystem Analysis
6.5 Industry Trends
6.5.1 Automation of Clinical Laboratory Techniques
6.5.2 Microfluidics-Based Poc and Lab-On-A-Chip Diagnostic Devices for Laboratory Testing
6.5.3 Growing Number of Reagent Rental Agreements
6.6 Regulatory Overview
6.6.1 US
Table 4 US: Classification of In-Vitro Diagnostic Devices
Figure 21 US: Regulatory Process for IVD Devices
6.6.2 Canada
Figure 22 Canada: Regulatory Process for IVD Devices in Canada
6.6.3 Europe
Table 5 Europe: Classification of IVD Devices
Figure 23 Europe: Regulatory Process for IVD Devices
6.6.4 Japan
Figure 24 Regulatory Process for IVD Devices in Japan
Table 6 Japan: Classification of IVD Reagents Classification of IVD Reagents in Japan
Table 7 Japan: Time, Cost, and Complexity of Registration Process
6.6.5 China
Table 8 China: Time, Cost, and Complexity of Registration Process
6.6.6 India
Figure 25 India: Regulatory Process for IVD Devices
6.6.7 Indonesia
Table 9 Indonesia: Registration Process for IVD Devices
6.6.8 Russia
Table 10 Russia: Classification of IVD Devices
6.6.9 Saudi Arabia
Table 11 Saudi Arabia: Time, Cost, and Complexity of Registration Process
6.6.10 Mexico
Figure 26 Mexico: Regulatory Process for IVD Devices
Table 12 Mexico: Time, Cost, and Complexity of Registration Process
6.6.11 Brazil
Figure 27 Brazil: Regulatory Process for IVD Devices
6.6.12 South Korea
Table 13 South Korea: Time, Cost, and Complexity of Registration Process
6.7 Vendor Benchmarking
Table 14 In-Vitro Diagnostic Products & Services Market: Product Portfolio Analysis

7 In-Vitro Diagnostics Market, by Product & Service
7.1 Introduction
Table 15 IVD Market, by Product & Service, 2018-2025 (USD Million)
7.2 Reagents & Kits
Table 16 IVD Reagents & Kits Market, by Country, 2018-2025 (USD Million)
Table 17 IVD Reagents & Kits Market, by Technology, 2018-2025 (USD Million)
7.3 Instruments
Table 18 IVD Instruments Market, by Type, 2018-2025 (USD Million)
Table 19 IVD Instruments Market, by Country, 2018-2025 (USD Million)
Table 20 IVD Instruments Market, by Technology, 2018-2025 (USD Million)
7.3.1 Semi-Automated Instruments
Table 21 Semi-Automated IVD Instruments Market, by Country, 2018-2025 (USD Million)
7.3.2 Fully Automated Instruments
Table 22 Major Lab Automation Systems & Fully Automated Instruments in the Market
Table 23 Fully Automated IVD Instruments Market, by Country, 2018-2025 (USD Million)
7.3.3 Other Instruments
Table 24 Other IVD Instruments Market, by Country, 2018-2025 (USD Million)
7.4 Services
Figure 28 Types of In-Vitro Diagnostic Services
Table 25 IVD Services Market, by Country, 2018-2025 (USD Million)
Table 26 IVD Services Market, by Technology, 2018-2025 (USD Million)
7.5 Data Management Software
Table 27 Key Data Management Software Solutions Available in the Market
Table 28 IVD Data Management Software Market, by Country, 2018-2025 (USD Million)
Table 29 IVD Data Management Software Market, by Technology, 2018-2025 (USD Million)

8 In-Vitro Diagnostics Market, by Technology
8.1 Introduction
Table 30 IVD Market, by Technology, 2018-2025 (USD Million)
8.2 Immunoassay/Immunochemistry
Table 31 Immunoassay/Immunochemistry Analyzers Available in the Market
Table 32 Immunoassay/Immunochemistry Market, by Type, 2018-2025 (USD Million)
Table 33 Immunoassay/Immunochemistry Market, by Country, 2018-2025 (USD Million)
8.2.1 Enzyme-Linked Immunosorbent Assays
Table 34 Elisa Analyzers Available in the Market
Table 35 Enzyme-Linked Immunosorbent Assays Market, by Country, 2018-2025 (USD Million)
Table 36 Enzyme-Linked Immunosorbent Assays Market, by Type, 2018-2025 (USD Million)
8.2.1.1 Chemiluminescence Immunoassays
Table 37 Chemiluminescence Immunoassay Systems Available in the Market
Table 38 Chemiluminescence Immunoassays Market, by Country, 2018-2025 (USD Million)
8.2.1.2 Fluorescence Immunoassays
Table 39 Fluorescence Immunoassays Market, by Country, 2018-2025 (USD Million)
8.2.1.3 Colorimetric Immunoassays
Table 40 Colorimetric Immunoassays Market, by Country, 2018-2025 (USD Million)
8.2.2 Radioimmunoassays
Table 41 Radioimmunoassays Market, by Country, 2018-2025 (USD Million)
8.2.3 Rapid Tests
Table 42 Rapid Tests Available in the Market
Table 43 Rapid Tests Market, by Country, 2018-2025 (USD Million)
8.2.4 Western Blotting
Table 44 Western Blotting Systems Available in the Market
Table 45 Western Blotting Market, by Country, 2018-2025 (USD Million)
8.2.5 Enzyme-Linked Immunospot Assays
Table 46 Elispot Assays Market, by Country, 2018-2025 (USD Million)
8.3 Clinical Chemistry
Table 47 Clinical Chemistry Analyzers for High- and Mid-Volume Laboratories
Table 48 Clinical Chemistry Analyzers for Low-Volume Laboratories
Table 49 Blood Gas Analyzers Available in the Market
Table 50 Clinical Chemistry Market, by Country, 2018-2025 (USD Million)
Table 51 Clinical Chemistry Market, by Test Type, 2018-2025 (USD Million)
8.3.1 Basic Metabolic Panels
Table 52 Basic Metabolic Panels Market, by Country, 2018-2025 (USD Million)
8.3.2 Liver Panels
Table 53 Liver Panels Market, by Country, 2018-2025 (USD Million)
8.3.3 Renal Profiles
Table 54 Renal Profiles Market, by Country, 2018-2025 (USD Million)
8.3.4 Lipid Profiles
Table 55 Lipid Profiles Market, by Country, 2018-2025 (USD Million)
8.3.5 Thyroid Function Panels
Table 56 Thyroid Function Panels Market, by Country, 2018-2025 (USD Million)
8.3.6 Electrolyte Panels
Table 57 Electrolyte Panels Market, by Country, 2018-2025 (USD Million)
8.3.7 Specialty Chemical Tests
Table 58 Specialty Chemical Tests Market, by Country, 2018-2025 (USD Million)
8.4 Molecular Diagnostics
Table 59 Automated Molecular Diagnostic Platforms Available in the Market
Table 60 Molecular Diagnostics Market, by Country, 2018-2025 (USD Million)
Table 61 Molecular Diagnostics Market, by Technology, 2018-2025 (USD Million)
8.4.1 Polymerase Chain Reaction
Table 62 Pcr Instruments Available in the Market
Table 63 Polymerase Chain Reaction Market, by Country, 2018-2025 (USD Million)
8.4.2 Isothermal Nucleic Acid Amplification Technology
Table 64 Isothermal Nucleic Acid Amplification Technology Market, by Country, 2018-2025 (USD Million)
8.4.3 Hybridization
Table 65 Hybridization Market, by Country, 2018-2025 (USD Million)
8.4.4 Dna Sequencing & Next-Generation Sequencing
Table 66 Ngs Instruments Available in the Market
Table 67 Dna Sequencing & Next-Generation Sequencing Market, by Country, 2018-2025 (USD Million)
8.4.5 Microarrays
Table 68 Microarrays Market, by Country, 2018-2025 (USD Million)
8.4.6 Other Mdx Technologies
Table 69 Other Molecular Diagnostic Technologies Market, by Country, 2018-2025 (USD Million)
8.5 Hematology
Table 70 Hematology Analyzers Available in the Market
Table 71 Hematology Market, by Country, 2018-2025 (USD Million)
8.6 Microbiology
Table 72 Microbiology Instruments Available in the Market
Table 73 Microbiology Market, by Country, 2018-2025 (USD Million)
8.7 Coagulation & Hemostasis
Table 74 Coagulation Analyzers Available in the Market
Table 75 Point-Of-Care/Self-Monitoring Coagulation Analyzers Available in the Market
Table 76 Coagulation & Hemostasis Market, by Country, 2018-2025 (USD Million)
8.8 Urinalysis
Table 77 Urinalysis Instruments Available in the Market
Table 78 Urinalysis Market, by Country, 2018-2025 (USD Million)
8.9 Other Technologies
Table 79 Blood Glucose Testing Systems Available in the Market
Table 80 Tissue Processors, Embedders, Microtomes, and Stainers Available in the Market
Table 81 Other Technologies Market, by Country, 2018-2025 (USD Million)

9 In-Vitro Diagnostics Market, by Application
9.1 Introduction
Table 82 IVD Market, by Application, 2018-2025 (USD Million)
9.2 Infectious Diseases
Table 83 IVD Market for Infectious Diseases, by Country, 2018-2025 (USD Million)
9.3 Diabetes
Table 84 Global Diabetic Patient Population, 2019 Vs. 2030 (Million)
Table 85 IVD Market for Diabetes, by Country, 2018-2025 (USD Million)
9.4 Oncology
Table 86 IVD Market for Oncology, by Country, 2018-2025 (USD Million)
9.5 Cardiology
Table 87 IVD Market for Cardiology, by Country, 2018-2025 (USD Million)
9.6 Drug Testing/Pharmacogenomics
Table 88 IVD Market for Drug Testing/Pharmacogenomics, by Country, 2018-2025 (USD Million)
9.7 Hiv/Aids
Table 89 IVD Market for Hiv/Aids, by Country, 2018-2025 (USD Million)
9.8 Autoimmune Diseases
Table 90 IVD Market for Autoimmune Diseases, by Country, 2018-2025 (USD Million)
9.9 Nephrology
Table 91 IVD Market for Nephrology, by Country, 2018-2025 (USD Million)
9.10 Other Applications
Table 92 IVD Market for Other Applications, by Country, 2018-2025 (USD Million)

10 In-Vitro Diagnostics Market, by End-user
10.1 Introduction
Table 93 IVD Market, by End-user, 2018-2025 (USD Million)
10.2 Hospital Laboratories
Table 94 IVD Market for Hospital Laboratories, by Country, 2018-2025 (USD Million)
10.3 Clinical Laboratories
Table 95 IVD Market for Clinical Laboratories, by Type, 2018-2025 (USD Million)
Table 96 IVD Market for Clinical Laboratories, by Country, 2018-2025 (USD Million)
10.3.1 Large/Reference Laboratories
Table 97 Large/Reference Laboratories Market, by Country, 2018-2025 (USD Million)
10.3.2 Medium-Sized Laboratories
Table 98 Medium-Sized Laboratories Market, by Country, 2018-2025 (USD Million)
10.3.3 Small Laboratories
Table 99 Small Laboratories Market, by Country, 2018-2025 (USD Million)
10.4 Point-Of-Care Testing
Table 100 IVD Market for Poc Testing, by Country, 2018-2025 (USD Million)
10.5 Patient Self-Testing
Table 101 IVD Market for Patient Self-Testing, by Country, 2018-2025 (USD Million)
10.6 Academic Institutes
Table 102 IVD Market for Academic Institutes, by Country, 2018-2025 (USD Million)
10.7 Other End-users
Table 103 IVD Market for Other End-users, by Country, 2018-2025 (USD Million)

11 In-Vitro Diagnostics Market, by Region
11.1 Introduction
Table 104 IVD Market, by Region, 2018-2025 (USD Million)
11.2 North America
Figure 29 North America: IVD Market Snapshot
Table 105 North America: IVD Market, by Country, 2018-2025 (USD Million)
Table 106 North America: IVD Market, by Product & Service, 2018-2025 (USD Million)
Table 107 North America: IVD Instruments Market, by Type, 2018-2025 (USD Million)
Table 108 North America: IVD Market, by Application, 2018-2025 (USD Million)
Table 109 North America: IVD Market, by Technology, 2018-2025 (USD Million)
Table 110 North America: IVD Market, by End-user, 2018-2025 (USD Million)
Table 111 North America: IVD Market for Clinical Laboratories, by Type, 2018-2025 (USD Million)
11.2.1 US
Table 112 US: IVD Market, by Product & Service, 2018-2025 (USD Million)
Table 113 US: IVD Instruments Market, by Type, 2018-2025 (USD Million)
Table 114 US: IVD Market, by Technology, 2018-2025 (USD Million)
Table 115 US: IVD Market, by Application, 2018-2025 (USD Million)
Table 116 US: IVD Market, by End-user, 2018-2025 (USD Million)
Table 117 US: IVD Market for Clinical Laboratories, by Type, 2018-2025 (USD Million)
11.2.2 Canada
Table 118 Canada: IVD Market, by Product & Service, 2018-2025 (USD Million)
Table 119 Canada: IVD Instruments Market, by Type, 2018-2025 (USD Million)
Table 120 Canada: IVD Market, by Technology, 2018-2025 (USD Million)
Table 121 Canada: IVD Market, by Application, 2018-2025 (USD Million)
Table 122 Canada: IVD Market, by End-user, 2018-2025 (USD Million)
Table 123 Canada: IVD Market for Clinical Laboratories, by Type, 2018-2025 (USD Million)
11.3 Europe
Figure 30 Europe: IVD Market Snapshot
Table 124 Europe: IVD Market, by Country, 2018-2025 (USD Million)
Table 125 Europe: IVD Market, by Product & Service, 2018-2025 (USD Million)
Table 126 Europe: IVD Instruments Market, by Type, 2018-2025 (USD Million)
Table 127 Europe: IVD Market, by Technology, 2018-2025 (USD Million)
Table 128 Europe: IVD Market, by Application, 2018-2025 (USD Million)
Table 129 Europe: IVD Market, by End-user, 2018-2025 (USD Million)
Table 130 Europe: IVD Market for Clinical Laboratories, by Type, 2018-2025 (USD Million)
11.3.1 Germany
Table 131 Germany: IVD Market, by Product & Service, 2018-2025 (USD Million)
Table 132 Germany: IVD Instruments Market, by Type, 2018-2025 (USD Million)
Table 133 Germany: IVD Market, by Technology, 2018-2025 (USD Million)
Table 134 Germany: IVD Market, by Application, 2018-2025 (USD Million)
Table 135 Germany: IVD Market, by End-user, 2018-2025 (USD Million)
Table 136 Germany: IVD Market for Clinical Laboratories, by Type, 2018-2025 (USD Million)
11.3.2 France
Table 137 France: IVD Market, by Product & Service, 2018-2025 (USD Million)
Table 138 France: IVD Instruments Market, by Type, 2018-2025 (USD Million)
Table 139 France: IVD Market, by Technology, 2018-2025 (USD Million)
Table 140 France: IVD Market, by Application, 2018-2025 (USD Million)
Table 141 France: IVD Market, by End-user, 2018-2025 (USD Million)
Table 142 France: IVD Market for Clinical Laboratories, by Type, 2018-2025 (USD Million)
11.3.3 UK
Table 143 UK: IVD Market, by Product & Service, 2018-2025 (USD Million)
Table 144 UK: IVD Instruments Market, by Type, 2018-2025 (USD Million)
Table 145 UK: IVD Market, by Technology, 2018-2025 (USD Million)
Table 146 UK: IVD Market, by Application, 2018-2025 (USD Million)
Table 147 UK: IVD Market, by End-user, 2018-2025 (USD Million)
Table 148 UK: IVD Market for Clinical Laboratories, by Type, 2018-2025 (USD Million)
11.3.4 Italy
Table 149 Italy: IVD Market, by Product & Service, 2018-2025 (USD Million)
Table 150 Italy: IVD Instruments Market, by Type, 2018-2025 (USD Million)
Table 151 Italy: IVD Market, by Technology, 2018-2025 (USD Million)
Table 152 Italy: IVD Market, by Application, 2018-2025 (USD Million)
Table 153 Italy: IVD Market, by End-user, 2018-2025 (USD Million)
Table 154 Italy: IVD Market for Clinical Laboratories, by Type, 2018-2025 (USD Million)
11.3.5 Spain
Table 155 Spain: IVD Market, by Product & Service, 2018-2025 (USD Million)
Table 156 Spain: IVD Instruments Market, by Type, 2018-2025 (USD Million)
Table 157 Spain: IVD Market, by Technology, 2018-2025 (USD Million)
Table 158 Spain: IVD Market, by Application, 2018-2025 (USD Million)
Table 159 Spain: IVD Market, by End-user, 2018-2025 (USD Million)
Table 160 Spain: IVD Market for Clinical Laboratories, by Type, 2018-2025 (USD Million)
11.3.6 Russia
Table 161 Russia: IVD Market, by Product & Service, 2018-2025 (USD Million)
Table 162 Russia: IVD Instruments Market, by Type, 2018-2025 (USD Million)
Table 163 Russia: IVD Market, by Technology, 2018-2025 (USD Million)
Table 164 Russia: IVD Market, by Application, 2018-2025 (USD Million)
Table 165 Russia: IVD Market, by End-user, 2018-2025 (USD Million)
Table 166 Russia: IVD Market for Clinical Laboratories, by Type, 2018-2025 (USD Million)
11.3.7 Rest of Europe
Table 167 Roe: IVD Market, by Product & Service, 2018-2025 (USD Million)
Table 168 Roe: IVD Instruments Market, by Type, 2018-2025 (USD Million)
Table 169 Roe: IVD Market, by Technology, 2018-2025 (USD Million)
Table 170 Roe: IVD Market, by Application, 2018-2025 (USD Million)
Table 171 Roe: IVD Market, by End-user, 2018-2025 (USD Million)
Table 172 Roe: IVD Market for Clinical Laboratories, by Type, 2018-2025 (USD Million)
11.4 Asia-Pacific
Figure 31 Asia-Pacific: IVD Market Snapshot
Table 173 Asia-Pacific: IVD Market, by Country, 2018-2025 (USD Million)
Table 174 Asia-Pacific: IVD Market, by Product & Service, 2018-2025 (USD Million)
Table 175 Asia-Pacific: IVD Instruments Market, by Type, 2018-2025 (USD Million)
Table 176 Asia-Pacific: IVD Market, by Technology, 2018-2025 (USD Million)
Table 177 Asia-Pacific: IVD Market, by Application, 2018-2025 (USD Million)
Table 178 Asia-Pacific: IVD Market, by End-user, 2018-2025 (USD Million)
Table 179 Asia-Pacific: IVD Market for Clinical Laboratories, by Type, 2018-2025 (USD Million)
11.4.1 Japan
Table 180 Japan: IVD Market, by Product & Service, 2018-2025 (USD Million)
Table 181 Japan: IVD Instruments Market, by Type, 2018-2025 (USD Million)
Table 182 Japan: IVD Market, by Technology, 2018-2025 (USD Million)
Table 183 Japan: IVD Market, by Application, 2018-2025 (USD Million)
Table 184 Japan: IVD Market, by End-user, 2018-2025 (USD Million)
Table 185 Japan: IVD Market for Clinical Laboratories, by Type, 2018-2025 (USD Million)
11.4.2 China
Table 186 China: IVD Market, by Product & Service, 2018-2025 (USD Million)
Table 187 China: IVD Instruments Market, by Type, 2018-2025 (USD Million)
Table 188 China: IVD Market, by Technology, 2018-2025 (USD Million)
Table 189 China: IVD Market, by Application, 2018-2025 (USD Million)
Table 190 China: IVD Market, by End-user, 2018-2025 (USD Million)
Table 191 China: IVD Market for Clinical Laboratories, by Type, 2018-2025 (USD Million)
11.4.3 India
Table 192 India: IVD Market, by Product & Service, 2018-2025 (USD Million)
Table 193 India: IVD Instruments Market, by Type, 2018-2025 (USD Million)
Table 194 India: IVD Market, by Technology, 2018-2025 (USD Million)
Table 195 India: IVD Market, by Application, 2018-2025 (USD Million)
Table 196 India: IVD Market, by End-user, 2018-2025 (USD Million)
Table 197 India: IVD Market for Clinical Laboratories, by Type,2018-2025 (USD Million)
11.4.4 South Korea
Table 198 South Korea: IVD Market, by Product & Service, 2018-2025 (USD Million)
Table 199 South Korea: IVD Instruments Market, by Type,2018-2025 (USD Million)
Table 200 South Korea: IVD Market, by Technology, 2018-2025 (USD Million)
Table 201 South Korea: IVD Market, by Application, 2018-2025 (USD Million)
Table 202 South Korea: IVD Market, by End-user, 2018-2025 (USD Million)
Table 203 South Korea: IVD Market for Clinical Laboratories, by Type, 2018-2025 (USD Million)
11.4.5 Indonesia
Table 204 Indonesia: IVD Market, by Product & Service, 2018-2025 (USD Million)
Table 205 Indonesia: IVD Instruments Market, by Type, 2018-2025 (USD Million)
Table 206 Indonesia: IVD Market, by Technology, 2018-2025 (USD Million)
Table 207 Indonesia: IVD Market, by Application, 2018-2025 (USD Million)
Table 208 Indonesia: IVD Market, by End-user, 2018-2025 (USD Million)
Table 209 Indonesia: IVD Market for Clinical Laboratories, by Type, 2018-2025 (USD Million)
11.4.6 Rest of Asia-Pacific
Table 210 Roapac: IVD Market, by Product & Service, 2018-2025 (USD Million)
Table 211 Roapac: IVD Instruments Market, by Type, 2018-2025 (USD Million)
Table 212 Roapac: IVD Market, by Technology, 2018-2025 (USD Million)
Table 213 Roapac: IVD Market, by Application, 2018-2025 (USD Million)
Table 214 Roapac: IVD Market, by End-user, 2018-2025 (USD Million)
Table 215 Roapac: IVD Market for Clinical Laboratories, by Type, 2018-2025 (USD Million)
11.5 Latin America
Table 216 Latin America: IVD Market, by Country, 2018-2025 (USD Million)
Table 217 Latin America: IVD Market, by Product & Service, 2018-2025 (USD Million)
Table 218 Latin America: IVD Instruments Market, by Type, 2018-2025 (USD Million)
Table 219 Latin America: IVD Market, by Technology, 2018-2025 (USD Million)
Table 220 Latin America: IVD Market, by Application, 2018-2025 (USD Million)
Table 221 Latin America: IVD Market, by End-user, 2018-2025 (USD Million)
Table 222 Latin America: IVD Market for Clinical Laboratories, by Type, 2018-2025 (USD Million)
11.5.1 Brazil
Table 223 Brazil: IVD Market, by Product & Service, 2018-2025 (USD Million)
Table 224 Brazil: IVD Instruments Market, by Type, 2018-2025 (USD Million)
Table 225 Brazil: IVD Market, by Technology, 2018-2025 (USD Million)
Table 226 Brazil: IVD Market, by Application, 2018-2025 (USD Million)
Table 227 Brazil: IVD Market, by End-user, 2018-2025 (USD Million)
Table 228 Brazil: IVD Market for Clinical Laboratories, by Type, 2018-2025 (USD Million)
11.5.2 Mexico
Table 229 Mexico: IVD Market, by Product & Service, 2018-2025 (USD Million)
Table 230 Mexico: IVD Instruments Market, by Type, 2018-2025 (USD Million)
Table 231 Mexico: IVD Market, by Technology, 2018-2025 (USD Million)
Table 232 Mexico: IVD Market, by Application, 2018-2025 (USD Million)
Table 233 Mexico: IVD Market, by End-user, 2018-2025 (USD Million)
Table 234 Mexico: IVD Market for Clinical Laboratories, by Type, 2018-2025 (USD Million)
11.5.3 Rest of Latin America
Table 235 Rola: IVD Market, by Product & Service, 2018-2025 (USD Million)
Table 236 Rola: IVD Instruments Market, by Type, 2018-2025 (USD Million)
Table 237 Rola: IVD Market, by Technology, 2018-2025 (USD Million)
Table 238 Rola: IVD Market, by Application, 2018-2025 (USD Million)
Table 239 Rola: IVD Market, by End-user, 2018-2025 (USD Million)
Table 240 Rola: IVD Market for Clinical Laboratories, by Type, 2018-2025 (USD Million)
11.6 Middle East & Africa
Table 241 Middle East & Africa: IVD Market, by Country, 2018-2025 (USD Million)
Table 242 Middle East & Africa: IVD Market, by Product & Service, 2018-2025 (USD Million)
Table 243 Middle East & Africa: IVD Instruments Market, by Type, 2018-2025 (USD Million)
Table 244 Middle East & Africa: IVD Market, by Technology, 2018-2025 (USD Million)
Table 245 Middle East & Africa: IVD Market, by Application, 2018-2025 (USD Million)
Table 246 Middle East & Africa: IVD Market, by End-user, 2018-2025 (USD Million)
Table 247 Middle East & Africa: IVD Market for Clinical Laboratories, by Type, 2018-2025 (USD Million)
11.6.1 Saudi Arabia
Table 248 Saudi Arabia: IVD Market, by Product & Service, 2018-2025 (USD Million)
Table 249 Saudi Arabia: IVD Instruments Market, by Type, 2018-2025 (USD Million)
Table 250 Saudi Arabia: IVD Market, by Technology, 2018-2025 (USD Million)
Table 251 Saudi Arabia: IVD Market, by End-user, 2018-2025 (USD Million)
Table 252 Saudi Arabia: IVD Market for Clinical Laboratories, by Type, 2018-2025 (USD Million)
11.6.2 Rest of Middle East & Africa (Romea)
Table 253 Romea: IVD Market, by Product & Service, 2018-2025 (USD Million)
Table 254 Romea: IVD Instruments Market, by Type, 2018-2025 (USD Million)
Table 255 Romea: IVD Market, by Technology, 2018-2025 (USD Million)
Table 256 Romea: IVD Market, by Application, 2018-2025 (USD Million)
Table 257 Romea: IVD Market, by End-user, 2018-2025 (USD Million)
Table 258 Romea: IVD Market for Clinical Laboratories, by Type, 2018-2025 (USD Million)

12 Competitive Landscape
12.1 Introduction
Figure 32 Key Developments in the IVD Market
12.2 Competitive Evaluation Matrix
12.2.1 Stars
12.2.2 Emerging Leaders
12.2.3 Pervasive Players
12.2.4 Participants
Figure 33 IVD Market: Competitive Leadership Mapping (2019)
12.3 Market Share Analysis
Figure 34 Global In-Vitro Diagnostics Market Share Analysis, by Key Player (2019)
12.3.1 Market Share Analysis, by Technology
12.3.1.1 Clinical Chemistry
Figure 35 Global Clinical Chemistry Market Share Analysis, by Key Player (2019)
12.3.1.2 Immunochemistry/Immunoassay Analyzers
Figure 36 Global Immunoassays Market Share Analysis, by Key Player (2019)
12.3.1.3 Clinical Microbiology Systems
Figure 37 Global Microbiology Market Share Analysis, by Key Player (2019)
12.3.1.4 Molecular Diagnostics
Figure 38 Global Molecular Diagnostics Market Share Analysis, by Key Player (2019)
12.3.1.5 Hematology
Figure 39 Global Hematology Market Share Analysis, by Key Player (2019)
12.3.1.6 Clinical Coagulation Analyzers
Figure 40 Global Clinical Coagulation Analyzers Market Share Analysis, by Key Player (2019)
12.4 Competitive Situation and Trends
12.4.1 Product Launches & Approvals
Table 259 Product Launches & Approvals
12.4.2 Agreements, Partnerships, and Collaborations
Table 260 Agreements, Partnerships, and Collaborations
12.4.3 Acquisitions
Table 261 Acquisitions
12.4.4 Expansions
Table 262 Expansions

13 Company Profiles
13.1 Roche Diagnostics
Figure 41 F. Hoffmann-La Roche: Company Snapshot (2019)
13.2 Danaher Corporation
Figure 42 Danaher Corporation: Company Snapshot (2019)
13.3 Abbott Laboratories, Inc.
Figure 43 Abbott Laboratories: Company Snapshot (2019)
13.4 Siemens Healthineers
Figure 44 Siemens Healthineers: Company Snapshot (2019)
13.5 Sysmex Corporation
Figure 45 Sysmex Corporation: Company Snapshot (2019)
13.6 Thermo Fisher Scientific
Figure 46 Thermo Fisher Scientific: Company Snapshot (2016)
13.7 Becton, Dickinson and Company
Figure 47 Becton, Dickinson and Company: Company Snapshot (2019)
13.8 Biomérieux Sa
Figure 48 Biomérieux Sa: Company Snapshot (2019)
13.9 Bio-Rad Laboratories, Inc.
Figure 49 Bio-Rad Laboratories: Company Snapshot (2019)
13.1 Johnson & Johnson
Figure 50 Johnson & Johnson: Company Snapshot (2019)
13.11 Agilent Technologies
Figure 51 Agilent Technologies: Company Snapshot (2019)
13.12 Qiagen
Figure 52 Qiagen: Company Snapshot (2019)
13.13 Diasorin
Figure 53 Diasorin: Company Snapshot (2019)
13.14 Ortho Clinical Diagnostics (A Part of Carlyle Group)
13.15 Speedx Diagnostics
13.16 Genspeed Biotech GmbH
13.17 Genomeme
13.18 Accelerate Diagnostics, Inc.
13.19 Msdx
13.20 Caris Life Sciences, Inc.

14 Appendix
14.1 Discussion Guide
14.2 Knowledge Store: The Subscription Portal
14.3 Available Customizations

Note: Product cover images may vary from those shown
3 of 6

Loading
LOADING...

4 of 6
5 of 6
  • Abbott Laboratories, Inc.
  • Accelerate Diagnostics, Inc.
  • Agilent Technologies
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • Biomérieux Sa
  • Caris Life Sciences, Inc.
  • Danaher Corporation
  • Diasorin
  • Genomeme
  • Genspeed Biotech GmbH
  • Johnson & Johnson
  • MSDX
  • Ortho Clinical Diagnostics (A Part of Carlyle Group)
  • Qiagen
  • Roche Diagnostics
  • Siemens Healthineers
  • Speedx Diagnostics
  • Sysmex Corporation
  • Thermo Fisher Scientific
Note: Product cover images may vary from those shown
6 of 6

Loading
LOADING...

Adroll
adroll